US20160250336A1 - Chinese herb medicine composition in the form of jelly - Google Patents

Chinese herb medicine composition in the form of jelly Download PDF

Info

Publication number
US20160250336A1
US20160250336A1 US15/150,745 US201615150745A US2016250336A1 US 20160250336 A1 US20160250336 A1 US 20160250336A1 US 201615150745 A US201615150745 A US 201615150745A US 2016250336 A1 US2016250336 A1 US 2016250336A1
Authority
US
United States
Prior art keywords
chinese herbal
agent
total amount
medical composition
per total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/150,745
Inventor
Tsunehiro Fukuchi
Koji Matsuura
Noboru Tatsumi
Masatake Dairaku
Mitsuo Togashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teikoku Seiyaku Co Ltd
Original Assignee
Teikoku Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co Ltd filed Critical Teikoku Seiyaku Co Ltd
Priority to US15/150,745 priority Critical patent/US20160250336A1/en
Publication of US20160250336A1 publication Critical patent/US20160250336A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/64Orobanchaceae (Broom-rape family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Definitions

  • the present invention relates to a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to Chinese herbal medicine ( ), and can be orally taken without taking care of the bitter taste, etc., of the Chinese herbal medicine.
  • the traditional Chinese herbal medicines are in the forms of liquids prepared by decocting crude drugs ( ), powders prepared by powdering crude drugs or pills made of crude drugs and honey.
  • Chinese herbal medicines have the disadvantages of being inconvenient due to the time required to decoct crude drugs, and due to having to prepare it according to necessity. Furthermore, it is painful or difficult for a patient to take the decoction or the powdered crude drug, due to the bitter taste or smell, which are peculiar to Chinese herbal medicines.
  • Chinese herbal medical preparations such as extracts from a Chinese herbal medicine, powders, granules, tablets, liquids, etc., are prepared starting from the powdered crude drugs. These preparations solve the inconveniences due to taking time to decoct crude drugs, and having to prepare it according to necessity. These preparations are also superior in preservative stability.
  • a patient must take several grams of preparation in the form of powders, granules or tablets, and this is a burden for the patient. Further, the powders and the granules can cause problems such as choking, resulting in a sandy feeling in a mouth, or getting between false teeth when they are taken.
  • the tablets can be too large for a patient to take.
  • the taste and smell peculiar to a Chinese herbal medicine is improved by tabletting it.
  • a Chinese herbal medicine is strongly tasted, is unpleasant, and is difficult to take when the contents in the tablets dissolve, or the tablets disintegrate in a mouth while taking them.
  • the liquids are more easily taken compared to the powders, the granules and the tablets.
  • the liquids have troubles in that the bitter taste and smell peculiar to a Chinese herbal medicine becomes strong, because the liquid is broadly spread in a mouth. Therefore, it is painful and difficult to take a liquid formulation. Furthermore, it is inconvenient to carry as it is packed in a glass-bottle. In order to solve such problems with a Chinese herbal medical preparation, it is considered to make a Chinese herbal medicine in the form of jelly.
  • a jelly preparation containing a Chinese herbal medicine there is known a jelly preparation made of a Chinese herbal medicine and gelatin (Japanese patent publication B 7-116049).
  • gelatin is a gelling agent which is physico-chemically unstable, the preparation lacks preservative stability and must be stored in a cold place. Therefore, it does not stand for the test for medicines (the long term-preservation test at 25° C. under 60% RH for 3 years, or the accelerated preservation test at 40° C. under 75% RH for 6 months, etc.).
  • gelatin is easily dissolved in a mouth and therefore, the preparation easily gives the bitter taste and is difficult to take when a Chinese herbal medicine having the strong bitter taste is contained.
  • a jelly preparation containing Chinese herbal medicine is prepared using sodium alginate or agar.
  • a jelly preparation containing a Chinese herbal medicine using sodium alginate a jelly preparation containing Sho-saiko-to is known ( ) (Japanese patent No. 2508547).
  • the bitter taste peculiar to a Chinese herbal medicine can be masked by adding alginic acid.
  • jelly containing alginic acid causes much syneresis, heterogeneity of the drug occurs and the drug remains in the packed vessel when taking it. The appearance is also bad. Therefore, the preparation is not preferable as a medicine.
  • the preparation causes much syneresis, similar to the preparation containing alginic acid. Further, the preparation easily disintegrates in a mouth, easily gives the bitter taste and does not give a good feeling when taking it.
  • the preparation contains as a starting material, a natural product which consists of a variety of ingredients, and many of these ingredients are structurally unknown.
  • starting materials such as crude drugs, liquid extract, condensed extract, dry extract, soft extract, fluid extract, etc., and the dosages on them vary.
  • the present invention was completed based on the above viewpoint and the goal is to provide a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of the bitter, etc., of a Chinese herbal medicine.
  • the present inventors have extensively studied to solve the above problems, and have found that by using at least one substance selected from the group consisting of carrageenan, carob bean gum and xanthan gum as a base (not containing phosphate buffer) of the jelly preparation containing a Chinese herbal medicine, a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of the bitter, etc., of a Chinese herbal medicine is obtainable.
  • the present invention was completed.
  • FIG. 1 shows a stick-like packed vessel which is sealed on three parts.
  • Carrageenan used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition.
  • there are ⁇ (kappa) type, ⁇ (iota) type and ⁇ (lambda) type with respect to carrageenan. Any type is usable, but preferably a combination of ⁇ type carrageenan and either ⁇ type carrageenan or ⁇ type carrageenan, or a combination of these three type carageenans, or ⁇ type carrageenan solely is usable.
  • ⁇ type carrageenan is usually used in the amount of more than 50 w/w % per total carageenan weight, preferably more than 70 w/w %, and more preferably more than 95 w/w %.
  • the amount of carageenan contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01 ⁇ 10.0 w/w % per total amount of the composition, more preferably 0.05 ⁇ 5.0 w/w %, and further more preferably 0.08 ⁇ 2.0 w/w %.
  • the amount of carrageenan is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • Carob bean gum used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition.
  • the amount of carob bean gum contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01 ⁇ 10.0 w/w % per total amount of the composition, more preferably 0.05 ⁇ 5.0 w/w %, and further more preferably 0.1 ⁇ 2.0 w/w %.
  • the amount of carob bean gum is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • Xanthan gum used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition.
  • the amount of xanthan gum contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01 ⁇ 10.0 w/w % per total amount of the composition, more preferably 0.05 ⁇ 5.0 w/w %, and further more preferably 0.08 ⁇ 2.0 w/w %.
  • the amount of xanthan gum is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • the amount of a Chinese herbal medicine contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably less than 60 w/w % per total amount of the composition, more preferably less than 50 w/w %, and further more preferably less than 30 w/w %.
  • the amount of the Chinese herbal medicine is beyond the above range, there is a possibility that the preparation becomes too viscous to prepare it and the jelly formation becomes difficult due to it being rice cake or jam-like.
  • a dispersion medium in order to disperse a base which is used for a Chinese herbal medical composition in the form of jelly of the present invention includes a liquid which is usually used as a dispersion medium of a jelly composition, for example water or a mixture of water and a polyalcohol.
  • the polyalcohol are glycerin, propylene glycol, etc.
  • the amount of the dispersion medium of a Chinese herbal medical composition in the form of jelly of the present invention is, preferably 30 ⁇ 90 w/w % per total composition, more preferably 30 ⁇ 85 w/w %, and further more preferably 40 ⁇ 80 w/w %.
  • the Chinese herbal medical composition in the form of jelly of the present invention may, if necessary, contain various known ingredients which are acceptable as medical additives and are orally administrable, such as stabilizing agents, correctives, sweetening agents, emulsifying agents, dispersion agents, preservatives, flavors, coloring agents, etc.
  • the stabilizing agent if desired, contained in the Chinese herbal medical composition in the form of jelly of the present invention includes ascorbic acid, disodium edetate, tocopherol, etc.
  • the corrective includes citric acid, malic acid, lactic acid, succinic acid, tartaric acid, ascorbic acid, a citrate, a malate, a lactate, a succinate, a tartarate, etc.
  • the sweetening agent includes glucose, fructose, saccharin sodium, sucrose, D-sorbitol, D-mannitol, hydrogenated maltose starch syrup, etc.
  • the emulsifying agent includes polyoxyethylene sorbitan monooleate, sodium lauryl sulfate, etc.
  • the dispersion agent includes an aqueous high molecular weight compound, such as carboxymethylcellulose, sodium alginate, hydroxypropylcellulose, hydroxyethylcellulose, etc.
  • the preservative includes methyl parahydroxybenzoate (methylparaben), ethyl parahydroxybenzoate (ethylparaben), etc.
  • the flavor includes ones such as menthols, fruit juices, or essential oils.
  • the coloring agent includes caramel, etc.
  • the raw material contained in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is an ordinary Chinese herbal medicine.
  • the raw material is not only limited to Chinese herbal medicines, but also the raw material made of natural plants is usable in the Chinese herbal medical composition in the form of jelly of the present invention.
  • the raw material selected from Chinese herbal medicines and natural plants is usable in combination with other active substances in the Chinese herbal medical composition in the form of jelly of the present invention.
  • a combination of a cold medicine, an antitussive, an expectorant, and/or a medicine for stomach with a western medicine is usable.
  • the raw material is not limited as long as it is a usual Chinese herbal medicine or natural plant.
  • a crude drug, liquid extract, condensed extract, dry extract, soft extract, fluid extract, etc. are illustrated.
  • the amount of the raw material may be contained in order that the suitable dosage is obtained when a Chinese herbal medical composition in the form of jelly is taken in the defined amount.
  • the method for preparing the Chinese herbal medical composition in the form of jelly of the present invention can be the same manner as in a usually known method for jelly preparations.
  • the suitable amount of warmed water as a dispersion medium is added to a base and a raw material and if necessary, a desired substance, and the mixture is stirred to be dispersed, dissolved or suspended, or otherwise the suitable amount of water or cold water as a dispersion medium is added to a base and a raw material and if necessary, a desired substance at room temperature.
  • the mixture is stirred under warming to be dispersed, dissolved or suspended and the resulting drug is cooled to prepare the Chinese herbal medical composition in the form of jelly.
  • an ingredient which is not preferable to be exposed to high temperature when contained among a base and a raw material and if necessary, a desired substance, it may be added after the dispersion, the solution or the suspension prepared above is adjusted to moderate temperature to prepare the Chinese herbal medical composition in the form of jelly. Otherwise an ingredient which is not preferable to be exposed to high temperature may be added thereto just before cooling to prepare the Chinese herbal medical composition in the form of jelly.
  • the packed vessel for the Chinese herbal medical composition in the form of jelly of the present invention is not specifically limited, but a stick-like vessel or a bag-like vessel is preferable in respect of carrying and taking it.
  • Example 1 resulted in a good Chinese herbal medical composition in the form of jelly, but the preparation of Comparative example 1 became like a rice cake without forming a jelly.
  • the preparations of Examples 2 ⁇ 4 and Comparative example 5 resulted in Chinese herbal medical compositions in the form of jelly, but the preparations of Comparative examples 2 ⁇ 4 containing sodium alginate did not form jelly.
  • the preparation of Comparative example 6 containing gelatin resulted in a Chinese herbal medical composition in the form of jelly in a refrigerator, but the preparation was a semi-solid at room temperature.
  • the preparations of Examples 8 ⁇ 10 resulted in good Chinese herbal medical compositions in the form of jelly.
  • the preparation of Comparative example 9 containing gelatin resulted in a Chinese herbal medical composition in the form of jelly in a refrigerator, but the preparation was a semi-solid at room temperature.
  • the preparation of Comparative example 9 was dissolved in a mouth and gave the bitter taste when it was taken, and did not give good feeling (see Table 7). The preparation did not serve as a medicine.
  • the Chinese herbal medical compositions in the form of jelly obtained were stored at 40° C. under 75% RH and at 25° C. under 60% RH, respectively.
  • the amount of syneresis and the strength of jelly were measured on each sample and their appearances were observed.
  • the method was carried out by standing on end a stick-like packed vessel sealed at three parts into which a Chinese herbal medical composition in the form of jelly was poured ( FIG. 1 ). The ratio of the weight of syneresis remained in the air portion per total amount was calculated.
  • the method was carried out by taking out a Chinese herbal medical composition in the form of jelly (sample) from a stick-like packed vessel sealed at three parts (see FIG. 1 ) after it was stored at 25° C. for 24 hours, and the sample was measured at 25° C. using a tool below.
  • Measuring tool Rheometer CR-200D (prepared by San Kagaku) Measuring conditions: Pressed speed, 30 mm/min Pressure-sensitive axis: Cross section 5 ⁇ 40 mm ⁇ height 15 mm (Stainless)
  • the Chinese herbal medical composition in the form of jelly of the present invention hardly shows syneresis for a long time and is superior in the preservative stability compared to a jelly preparation containing either gelatin or sodium alginate as a base.
  • the Chinese herbal medical composition in the form of jelly is obtained or not obtained depending on the raw material.
  • the good Chinese herbal medical composition in the form of jelly can be obtained regardless of the raw material.
  • Comparative example 7 gave the almost same result as the preparation of Example 10, and persons who answered with “too bitter to take it” and “bitter” were 1/10 and 9/10, respectively.
  • the preparation of Comparative example 7 like the preparation of Example 10 showed a better result than the aqueous solution (control), jelly preparations containing agar and gelatin, respectively (Comparative example 8 and 9).
  • the bitter taste is masked by adding sodium alginate to a bitter taste substance, it seems not to exhibit any masking effect as the extract was much.
  • Example 4 Comp. ex. 5 40° C. 75% RH After 2 days — — — — After one month 0.2% 0.4% 3.3% 8.2% After 3 months 0.3% 1.5% 4.0% — After 6 months 0.8% 1.9% 4.4% — 25° C. 60% RH After 2 days no no 2.3% 3.0% After one month 0.4% 0.6% 5.0% 9.2% After 3 months 1.2% 2.0% 4.8% — After 6 months 1.0% 2.3% 5.4% —
  • Example 4 Comp. ex. 5 40° C. 75% RH Before starting 293 g 300 g 90 g 143 g preservation After one month 290 g 314 g 88 g 191 g After 3 months 302 g 322 g 84 g — After 6 months 297 g 323 g 86 g — 25° C. 60% RH Before starting 293 g 300 g 90 g 143 g preservation After one month 285 g 304 g 87 g 180 g After 3 months 297 g 308 g 88 g — After 6 months 293 g 322 g 84 g —
  • a Chinese herbal medical composition in the form of jelly which hardy muses syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of bitter, etc., of a Chinese herbal medicine is obtainable. Furthermore, even when the Chinese herbal medical composition in the form of jelly of the present invention can stand for the test for medicines, for example the long term-preservation test at 25° C. under 60% RH for 3 years, and the accelerated preservation test at 40° C. under 75% RH for 6 months and is guaranteed in the preservative stability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese herbal medical composition in the form of jelly, wherein a Chinese herbal medicine is contained in a base containing at least one substance selected from the group consisting of carrageenan, carob bean gum and xanthan gum and not containing phosphate buffer. The Chinese herbal medical composition hardy muses syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine and is orally taken without taking care of the bitter of a Chinese herbal medicine.

Description

    TECHNICAL FIELD OF THE INVENTION
  • The present invention relates to a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to Chinese herbal medicine (
    Figure US20160250336A1-20160901-P00001
    ), and can be orally taken without taking care of the bitter taste, etc., of the Chinese herbal medicine.
  • BACKGROUND OF THE INVENTION
  • The traditional Chinese herbal medicines are in the forms of liquids prepared by decocting crude drugs (
    Figure US20160250336A1-20160901-P00002
    ), powders prepared by powdering crude drugs or pills made of crude drugs and honey.
  • Therefore, traditional Chinese herbal medicines have the disadvantages of being inconvenient due to the time required to decoct crude drugs, and due to having to prepare it according to necessity. Furthermore, it is painful or difficult for a patient to take the decoction or the powdered crude drug, due to the bitter taste or smell, which are peculiar to Chinese herbal medicines. Today, in order to solve such problems, Chinese herbal medical preparations, such as extracts from a Chinese herbal medicine, powders, granules, tablets, liquids, etc., are prepared starting from the powdered crude drugs. These preparations solve the inconveniences due to taking time to decoct crude drugs, and having to prepare it according to necessity. These preparations are also superior in preservative stability.
  • However, a patient must take several grams of preparation in the form of powders, granules or tablets, and this is a burden for the patient. Further, the powders and the granules can cause problems such as choking, resulting in a sandy feeling in a mouth, or getting between false teeth when they are taken. The tablets can be too large for a patient to take. The taste and smell peculiar to a Chinese herbal medicine is improved by tabletting it. However, there are still disadvantages in that a Chinese herbal medicine is strongly tasted, is unpleasant, and is difficult to take when the contents in the tablets dissolve, or the tablets disintegrate in a mouth while taking them.
  • On the other hand, the liquids are more easily taken compared to the powders, the granules and the tablets. However, the liquids have troubles in that the bitter taste and smell peculiar to a Chinese herbal medicine becomes strong, because the liquid is broadly spread in a mouth. Therefore, it is painful and difficult to take a liquid formulation. Furthermore, it is inconvenient to carry as it is packed in a glass-bottle. In order to solve such problems with a Chinese herbal medical preparation, it is considered to make a Chinese herbal medicine in the form of jelly.
  • As a jelly preparation containing a Chinese herbal medicine, there is known a jelly preparation made of a Chinese herbal medicine and gelatin (Japanese patent publication B 7-116049). As gelatin is a gelling agent which is physico-chemically unstable, the preparation lacks preservative stability and must be stored in a cold place. Therefore, it does not stand for the test for medicines (the long term-preservation test at 25° C. under 60% RH for 3 years, or the accelerated preservation test at 40° C. under 75% RH for 6 months, etc.). In addition, gelatin is easily dissolved in a mouth and therefore, the preparation easily gives the bitter taste and is difficult to take when a Chinese herbal medicine having the strong bitter taste is contained.
  • In addition, it is considered that a jelly preparation containing Chinese herbal medicine is prepared using sodium alginate or agar. As a jelly preparation containing a Chinese herbal medicine using sodium alginate, a jelly preparation containing Sho-saiko-to is known (
    Figure US20160250336A1-20160901-P00003
    ) (Japanese patent No. 2508547). The bitter taste peculiar to a Chinese herbal medicine can be masked by adding alginic acid. However, as jelly containing alginic acid causes much syneresis, heterogeneity of the drug occurs and the drug remains in the packed vessel when taking it. The appearance is also bad. Therefore, the preparation is not preferable as a medicine.
  • In regard to a jelly preparation prepared using agar, the preparation causes much syneresis, similar to the preparation containing alginic acid. Further, the preparation easily disintegrates in a mouth, easily gives the bitter taste and does not give a good feeling when taking it.
  • As other jelly preparations, a jelly composition (Japanese patent publication A 9-187233 and Japanese patent publication A 9-194346) and a Chinese herbal medical composition in the form of jelly (Japanese patent publication A 2001-114696) are known, but it is very difficult to prepare jelly preparations containing a Chinese herbal medicine which guarantees the preservative stability on a medical level.
  • The following reasons are considered as causes which make it difficult to make a Chinese herbal medicine in the form of jelly.
  • The preparation contains as a starting material, a natural product which consists of a variety of ingredients, and many of these ingredients are structurally unknown. In addition, there are many forms of starting materials, such as crude drugs, liquid extract, condensed extract, dry extract, soft extract, fluid extract, etc., and the dosages on them vary.
  • As there is such a background peculiar to a Chinese herbal medicine, when a Chinese herbal medicine is formed into a jelly preparation, according to the kind or amount of the contained Chinese herbal medicine, there are possibilities to produce the preparation wherein its appearance can not be maintained due to syneresis and the stability of the active ingredients can not be maintained. Therefore, a Chinese herbal medical composition in the form of jelly which is broadly applicable has been desired.
  • BRIEF SUMMARY OF THE INVENTION
  • The present invention was completed based on the above viewpoint and the goal is to provide a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of the bitter, etc., of a Chinese herbal medicine.
  • The present inventors have extensively studied to solve the above problems, and have found that by using at least one substance selected from the group consisting of carrageenan, carob bean gum and xanthan gum as a base (not containing phosphate buffer) of the jelly preparation containing a Chinese herbal medicine, a Chinese herbal medical composition in the form of jelly, which hardly causes syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of the bitter, etc., of a Chinese herbal medicine is obtainable. Thus, the present invention was completed.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a stick-like packed vessel which is sealed on three parts.
  • EXPLANATION OF SIGNS
      • 1: A Chinese herbal medical composition in the form of jelly
      • 2: Sealed parts.
    DETAILED DESCRIPTION OF THE INVENTION
  • Carrageenan used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition. For example, there are κ (kappa) type, ι (iota) type and λ (lambda) type, with respect to carrageenan. Any type is usable, but preferably a combination of ι type carrageenan and either κ type carrageenan or λ type carrageenan, or a combination of these three type carageenans, or ι type carrageenan solely is usable. When a combination of ι type carrageenan and either κ type carrageenan or λ type carrageenan, or a combination of these three type carageenans is used, ι type carrageenan is usually used in the amount of more than 50 w/w % per total carageenan weight, preferably more than 70 w/w %, and more preferably more than 95 w/w %.
  • The amount of carageenan contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01˜10.0 w/w % per total amount of the composition, more preferably 0.05˜5.0 w/w %, and further more preferably 0.08˜2.0 w/w %. When the amount of carrageenan is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • Carob bean gum used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition.
  • The amount of carob bean gum contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01˜10.0 w/w % per total amount of the composition, more preferably 0.05˜5.0 w/w %, and further more preferably 0.1˜2.0 w/w %. When the amount of carob bean gum is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • Xanthan gum used in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is usually used for a jelly composition.
  • The amount of xanthan gum contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably 0.01˜10.0 w/w % per total amount of the composition, more preferably 0.05˜5.0 w/w %, and further more preferably 0.08˜2.0 w/w %. When the amount of xanthan gum is beyond the above range, the preparation becomes too viscous to prepare it, and when the amount is below the above range, the jelly formation becomes difficult and the desired composition is not obtainable.
  • The amount of a Chinese herbal medicine contained in the Chinese herbal medical composition in the form of jelly of the present invention is preferably less than 60 w/w % per total amount of the composition, more preferably less than 50 w/w %, and further more preferably less than 30 w/w %. When the amount of the Chinese herbal medicine is beyond the above range, there is a possibility that the preparation becomes too viscous to prepare it and the jelly formation becomes difficult due to it being rice cake or jam-like.
  • A dispersion medium in order to disperse a base which is used for a Chinese herbal medical composition in the form of jelly of the present invention includes a liquid which is usually used as a dispersion medium of a jelly composition, for example water or a mixture of water and a polyalcohol. Examples of the polyalcohol are glycerin, propylene glycol, etc. The amount of the dispersion medium of a Chinese herbal medical composition in the form of jelly of the present invention is, preferably 30˜90 w/w % per total composition, more preferably 30˜85 w/w %, and further more preferably 40˜80 w/w %.
  • The Chinese herbal medical composition in the form of jelly of the present invention may, if necessary, contain various known ingredients which are acceptable as medical additives and are orally administrable, such as stabilizing agents, correctives, sweetening agents, emulsifying agents, dispersion agents, preservatives, flavors, coloring agents, etc.
  • The stabilizing agent, if desired, contained in the Chinese herbal medical composition in the form of jelly of the present invention includes ascorbic acid, disodium edetate, tocopherol, etc. The corrective includes citric acid, malic acid, lactic acid, succinic acid, tartaric acid, ascorbic acid, a citrate, a malate, a lactate, a succinate, a tartarate, etc. The sweetening agent includes glucose, fructose, saccharin sodium, sucrose, D-sorbitol, D-mannitol, hydrogenated maltose starch syrup, etc. The emulsifying agent includes polyoxyethylene sorbitan monooleate, sodium lauryl sulfate, etc. The dispersion agent includes an aqueous high molecular weight compound, such as carboxymethylcellulose, sodium alginate, hydroxypropylcellulose, hydroxyethylcellulose, etc. The preservative includes methyl parahydroxybenzoate (methylparaben), ethyl parahydroxybenzoate (ethylparaben), etc. The flavor includes ones such as menthols, fruit juices, or essential oils. The coloring agent includes caramel, etc.
  • The raw material contained in the Chinese herbal medical composition in the form of jelly of the present invention is not limited as long as it is an ordinary Chinese herbal medicine. For example, Kakkon-to (
    Figure US20160250336A1-20160901-P00004
    ), Sho-seiryu-to (
    Figure US20160250336A1-20160901-P00005
    ), Sho-saiko-to (
    Figure US20160250336A1-20160901-P00006
    ), Hachimi-jio-gan (
    Figure US20160250336A1-20160901-P00007
    ), Hochu-ekki-to (
    Figure US20160250336A1-20160901-P00008
    ), Sho-kenchu-to (
    Figure US20160250336A1-20160901-P00009
    ), Shofu-san (
    Figure US20160250336A1-20160901-P00010
    ), Seijo-bofu-to (
    Figure US20160250336A1-20160901-P00011
    ), Bofu-tsusho-san (
    Figure US20160250336A1-20160901-P00012
    ), Gorei-san (
    Figure US20160250336A1-20160901-P00013
    ), Boi-ogi-to (
    Figure US20160250336A1-20160901-P00014
    ), Otsuji-to (
    Figure US20160250336A1-20160901-P00015
    Figure US20160250336A1-20160901-P00016
    ), Toki-shakuyaku-san (
    Figure US20160250336A1-20160901-P00017
    ), Keishi-bukuryo-gan (
    Figure US20160250336A1-20160901-P00018
    ), Anchu-san (
    Figure US20160250336A1-20160901-P00019
    ), Heii-san (
    Figure US20160250336A1-20160901-P00020
    ), etc., are illustrated. Further, a variety of Chinese herbal medicines are usable as well. The raw material is not only limited to Chinese herbal medicines, but also the raw material made of natural plants is usable in the Chinese herbal medical composition in the form of jelly of the present invention. The raw material selected from Chinese herbal medicines and natural plants is usable in combination with other active substances in the Chinese herbal medical composition in the form of jelly of the present invention. For example, a combination of a cold medicine, an antitussive, an expectorant, and/or a medicine for stomach with a western medicine is usable.
  • The raw material is not limited as long as it is a usual Chinese herbal medicine or natural plant. For example, a crude drug, liquid extract, condensed extract, dry extract, soft extract, fluid extract, etc., are illustrated. The amount of the raw material may be contained in order that the suitable dosage is obtained when a Chinese herbal medical composition in the form of jelly is taken in the defined amount.
  • The method for preparing the Chinese herbal medical composition in the form of jelly of the present invention can be the same manner as in a usually known method for jelly preparations. For example, the suitable amount of warmed water as a dispersion medium is added to a base and a raw material and if necessary, a desired substance, and the mixture is stirred to be dispersed, dissolved or suspended, or otherwise the suitable amount of water or cold water as a dispersion medium is added to a base and a raw material and if necessary, a desired substance at room temperature. The mixture is stirred under warming to be dispersed, dissolved or suspended and the resulting drug is cooled to prepare the Chinese herbal medical composition in the form of jelly. Further, when an ingredient which is not preferable to be exposed to high temperature is contained among a base and a raw material and if necessary, a desired substance, it may be added after the dispersion, the solution or the suspension prepared above is adjusted to moderate temperature to prepare the Chinese herbal medical composition in the form of jelly. Otherwise an ingredient which is not preferable to be exposed to high temperature may be added thereto just before cooling to prepare the Chinese herbal medical composition in the form of jelly.
  • The packed vessel for the Chinese herbal medical composition in the form of jelly of the present invention is not specifically limited, but a stick-like vessel or a bag-like vessel is preferable in respect of carrying and taking it.
  • EXAMPLES
  • The present invention is explained by following examples and is not limited by these examples.
  • Examples 1˜4 and Comparative Examples 1˜6
  • In regard to Examples 1˜4 and Comparative examples 1, 5 and 6, the ingredients shown in Tables 1-1 and 1-2 were weighed and each ingredient was dissolved under heating at 80° C. The resulting solution was poured into a stick-like vessel sealed at three parts and cooled to prepare a Chinese herbal medical composition.
  • In regard to Comparative examples 2˜4, after sodium alginate was homogenously dissolved in water, it was warmed at 50˜60° C., and thereto were added aqueous dry extract of Kakkon-to (
    Figure US20160250336A1-20160901-P00021
    ). After the mixture was homogeneously dissolved for about 5 minutes, other residual ingredients were added thereto and stirred homogeneously. The mixture was poured into a stick-like vessel sealed at three parts and was cooled to prepare a Chinese herbal medical composition.
  • The preparation of Example 1 resulted in a good Chinese herbal medical composition in the form of jelly, but the preparation of Comparative example 1 became like a rice cake without forming a jelly. The preparations of Examples 2˜4 and Comparative example 5 resulted in Chinese herbal medical compositions in the form of jelly, but the preparations of Comparative examples 2˜4 containing sodium alginate did not form jelly. The preparation of Comparative example 6 containing gelatin resulted in a Chinese herbal medical composition in the form of jelly in a refrigerator, but the preparation was a semi-solid at room temperature.
  • Examples 5˜7
  • The ingredients shown in Table 2 were weighed and each ingredient was dissolved under heating at 80° C. The resulting solution was poured into a stick-like vessel sealed at three parts and was cooled to prepare a Chinese herbal medical composition in the form of jelly.
  • Examples 8˜10 and Comparative Examples 7˜9
  • In regard to Examples 8˜10 and Comparative examples 8 and 9, the ingredients shown in Table 3 were weighed and each ingredient was dissolved under heating at 80° C. The resulting solution was poured into a stick-like vessel sealed at three parts and was cooled to prepare a Chinese herbal medical composition in the form of jelly.
  • In regard to Comparative example 7, after sodium alginate was homogenously dissolved in water, it was warmed at 50˜60° C., and thereto were added aqueous dry extract of Seijo-bofu-to (
    Figure US20160250336A1-20160901-P00022
    ). After the mixture was homogeneously dissolved for about 5 minutes, other residual ingredients were added thereto and stirred homogeneously. The mixture was poured into a stick-like vessel sealed at three parts and was cooled to prepare a Chinese herbal medical composition in the form of jelly.
  • The preparations of Examples 8˜10 resulted in good Chinese herbal medical compositions in the form of jelly. The preparations of Comparative example 7 and Comparative example 8 containing sodium alginate and agar, respectively resulted in a Chinese herbal medical composition in the form of jelly. The preparation of Comparative example 9 containing gelatin resulted in a Chinese herbal medical composition in the form of jelly in a refrigerator, but the preparation was a semi-solid at room temperature. The preparation of Comparative example 9 was dissolved in a mouth and gave the bitter taste when it was taken, and did not give good feeling (see Table 7). The preparation did not serve as a medicine.
  • Measurement of the Amount of Syneresis and the Strength of Jelly
  • According to the method below, the Chinese herbal medical compositions in the form of jelly obtained were stored at 40° C. under 75% RH and at 25° C. under 60% RH, respectively. The amount of syneresis and the strength of jelly were measured on each sample and their appearances were observed.
  • The Method for Measuring the Amount of Syneresis
  • The method was carried out by standing on end a stick-like packed vessel sealed at three parts into which a Chinese herbal medical composition in the form of jelly was poured (FIG. 1). The ratio of the weight of syneresis remained in the air portion per total amount was calculated.
  • The Method for Measuring the Strength on Jelly
  • The method was carried out by taking out a Chinese herbal medical composition in the form of jelly (sample) from a stick-like packed vessel sealed at three parts (see FIG. 1) after it was stored at 25° C. for 24 hours, and the sample was measured at 25° C. using a tool below.
  • Measuring tool: Rheometer CR-200D (prepared by San Kagaku)
    Measuring conditions: Pressed speed, 30 mm/min
    Pressure-sensitive axis: Cross section 5×40 mm×height 15 mm (Stainless)
  • Results
  • The results obtained on syneresis of the preparations in the form of jelly of Examples 2˜4 and Comparative example 5 were shown in Table 4-1. The preparations of Examples 2˜4 were stored both at 40° C. under 75% RH and at 25° C. under 60% RH, and they hardly showed syneresis and their appearances were good. On the other hand, the preparation of Comparative example 5 containing agar showed much syneresis both at 40° C. under 75% RH and at 25° C. under 60% RH. Its appearance was bad and did not serve as a medicine.
  • The results obtained on the jelly strength on the preparations in the form of jelly of Examples 2˜4 and the preparation of Comparative example 5 were shown in Table 4-2. Changes on the jelly strength on the preparations of Examples 2˜4 were not observed under the preservation both at 40° C. under 75% RH and 25° C. under 60% RH. On the contrary, rapid increase of the jelly strength was observed on the preparation Comparative example 5 containing agar under the preservation both at 40° C. under 75% RH and at 25° C. under 60% RH in one month.
  • The preparations of Examples 5˜7 resulted in good Chinese herbal medical compositions in the form of jelly, hardly showed syneresis under the preservation conditions both at 0° C. under 75% RH and at 25° C. under 60% RH (see Table 5-1), their appearances were good and changes of the jelly strength on them were not observed (see Table 5-2).
  • The preparations of Examples 8˜10 resulted in good Chinese herbal medical compositions in the form of jelly, hardly showed syneresis under the preservation conditions both at 0° C. under 75% RH and at 25° C. under 60% RH (see Table 6-1). Their appearances were good and changes of the jelly strength on them were not observed (see Table 6-2).
  • On the contrary the preparations in the form of jelly of Comparative examples 7 and 8 showed much syneresis under the preservation conditions both at 0° C. under 75% RH and at 25° C. under 60% RH (see Table 6-1). Their appearances were bad and the jelly strength on them was greatly changed in one month and they could serve as a medicine (see Table 6-2).
  • As mentioned above, it was ascertained that the Chinese herbal medical composition in the form of jelly of the present invention hardly shows syneresis for a long time and is superior in the preservative stability compared to a jelly preparation containing either gelatin or sodium alginate as a base.
  • When sodium alginate is used as a base, the Chinese herbal medical composition in the form of jelly is obtained or not obtained depending on the raw material. On the contrast, according to the present invention the good Chinese herbal medical composition in the form of jelly can be obtained regardless of the raw material.
  • Masking Effect on Bitter Taste
  • By using Chinese herbal medical compositions in the form of jelly and a semi-solid preparation containing gelatin (Comparative example 9), which had the ingredients shown in Table 3, the organoleptic test was carried out. The panel tests were carried out by using 10 persons (5 males and 5 females) and the evaluation were shown as follows: ++: too bitter to take one, +: bitter, ±: slightly bitter, −: scarcely bitter, −−: no bitter A preparation which was prepared by dissolving aqueous dry extract of Seijo-bofu-to (
    Figure US20160250336A1-20160901-P00023
    ) 7 g in water (100 g) was used as a control.
  • As shown in Table 7, in regard to the Control and the preparations of Comparative examples 8 and 9, almost all persons answered with “too bitter to take them” (Control and Comparative example 9: 10/10, Comparative example 8: 8/10). On the contrast, in regard to the preparation of Example 10, persons who answered with “too bitter to take it” and “bitter” were 3/10 and 7/10, respectively and these preparations showed better result comparing with the preparations of Control and Comparative examples 8 and 9.
  • The preparation of Comparative example 7 gave the almost same result as the preparation of Example 10, and persons who answered with “too bitter to take it” and “bitter” were 1/10 and 9/10, respectively. The preparation of Comparative example 7 like the preparation of Example 10 showed a better result than the aqueous solution (control), jelly preparations containing agar and gelatin, respectively (Comparative example 8 and 9). Although it is known that the bitter taste is masked by adding sodium alginate to a bitter taste substance, it seems not to exhibit any masking effect as the extract was much.
  • In regard to the preparation of Example 9, persons who answered with “slightly bitter” were 7/10 and there was none who answered with “too bitter to take it”. In regard to the preparation of Example 8, persons who answered with “slightly bitter” were 8/10 and there was none who answered with “too bitter to take it” or “bitter”.
  • As mentioned above, it was ascertained that a Chinese herbal medical composition in the form of jelly wherein the bitter taste of a Chinese herbal medicine effectively masks was obtainable. Especially by solely using ι carrageenan, it was confirmed that the bitter taste of a Chinese herbal medicine which was contained in the high concentration was excellently masked. Furthermore, by adding a sweetening agent to the Chinese herbal medical composition in the form of jelly prepared by the present invention, it became possible to take it almost without taking care of the bitter taste of a Chinese herbal medicine.
  • TABLE 1-1
    Amount (weight %)
    Ingredient Ex. 1 Ex. 2 Ex. 3 Ex. 4
    Aqueous dry extract of Kakkon-to 30 15 15 15
    ( 
    Figure US20160250336A1-20160901-P00024
     )
    l Carrageenan 0.5 1 1
    K Carrageenan 0.05 1
    Carob bean gum 0.1 0.25 0.25 0.25
    Xanthan gum 0.2 0.45 0.45 0.45
    Sodium alginate
    Calcium monohydrogen phosphate
    Glucono-δ-lactone
    Agar
    Gelatin
    Powdered hydrogenated maltose 6 6 6
    starch syrup
    D-Sorbitol 6 6 6
    Glycerin 6 6 6
    Propylene glycol 1 1 1
    Propyl parahydroxybenzoate 0.02 0.02 0.02 0.02
    Purified water 69.18 64.28 64.23 64.28
    Total 100 100 100 100
  • TABLE 1-2
    Amount (weight %)
    Comp. Comp. Comp. Comp. Comp. Comp.
    Ingredient ex. 1* ex. 2* ex. 3* ex. 4* ex. 5 ex. 6*
    Aqueous dry extract of 65 5 15 15 15 15
    Kakkon-to ( 
    Figure US20160250336A1-20160901-P00025
     )
    ι Carrageenan 0.5
    κ Carrageenan
    Carob bean gum 0.1
    Xanthan gum 0.2
    Sodium alginate 0.8 0.8 2
    Calcium monohydrogen 0.2 0.2 0.5
    phosphate
    Gluclono-δ-lactone 2.2 2.2
    Agar 3
    Gelatin 7.5
    Powdered hydrogenated
    maltose starch syrup
    D-Sorbitol
    Glycerin
    Propylene glycol
    Propyl 0.02 0.02 0.02 0.02 0.02 0.02
    parahydroxybenzoate
    Purified water 34.18 91.78 81.78 82.48 81.98 77.48
    Total 100 100 100 100 100 100
    *not solidified
  • TABLE 2
    Amount (weight %)
    Ingredient Ex. 5 Ex. 6 Ex. 7
    Soft extract of Hachimi-jio-gan 14
    (
    Figure US20160250336A1-20160901-P00026
    Keishi-bukuryo-gan (
    Figure US20160250336A1-20160901-P00027
    )
    14 14
    (crude drug)
    l Carrageenan 1 1 1
    K Carrageenan 0.1
    Carob bean gum 0.2 0.25 0.25
    Xanthan gum 0.4 0.45 0.45
    Powdered hydrogenated maltose starch 6 6 6
    syrup
    D-Sorbitol 6 6 6
    Glycerin 6 6 6
    Propylene glycol 1 1 1
    Propyl parahydroxybenzoate 0.02 0.02 0.02
    Purified water 65.38 65.28 65.18
    Total 100 100 100
  • TABLE 3
    Amount (weight %)
    Comp. Comp. Comp.
    Ingredient Ex. 8 Ex. 9 Ex. 10 ex. 7 ex. 8 ex. 9* Control
    Aqueous dry extract of 14 14 14 14 14 7 7
    Seijo-bofu-to ( 
    Figure US20160250336A1-20160901-P00028
     )
    ι Carrageenan 1 1
    κ Carrageenan 1
    Carob bean gum 0.2 0.2 0.2
    Xanthan gum 0.4 0.4 0.4
    Sodium alginate 2
    Calcium monohydrogen 0.5
    phosphate
    Agar 3
    Gelatin 7.5
    Powdered hydrogenated 6
    maltose starch syrup
    D-Sorbitol 6
    Glycerin 6
    Propylene glycol 1
    Propyl 0.02 0.02 0.02 0.02 0.02 0.02 0.02
    parahydroxybenzoate
    Purified water 65.38 84.38 84.38 83.48 82.98 85.48 92.98
    Total 100 100 100 100 100 100 100
    *not solidified
  • TABLE 4-1
    Amount of syneresis
    (weight %) Example 2 Example 3 Example 4 Comp. ex. 5
    40° C. 75% RH
    After 2 days
    After one month 0.2% 0.4% 3.3% 8.2%
    After 3 months 0.3% 1.5% 4.0%
    After 6 months 0.8% 1.9% 4.4%
    25° C. 60% RH
    After 2 days no no 2.3% 3.0%
    After one month 0.4% 0.6% 5.0% 9.2%
    After 3 months 1.2% 2.0% 4.8%
    After 6 months 1.0% 2.3% 5.4%
  • TABLE 4-2
    Strength Example 2 Example 3 Example 4 Comp. ex. 5
    40° C. 75% RH
    Before starting 293 g 300 g 90 g 143 g
    preservation
    After one month 290 g 314 g 88 g 191 g
    After 3 months 302 g 322 g 84 g
    After 6 months 297 g 323 g 86 g
    25° C. 60% RH
    Before starting 293 g 300 g 90 g 143 g
    preservation
    After one month 285 g 304 g 87 g 180 g
    After 3 months 297 g 308 g 88 g
    After 6 months 293 g 322 g 84 g
  • TABLE 5-1
    Amount of syneresis (weight %)
    40° C. 75% RH 25° C. 60% RH
    Ex. 5 Ex. 6 Ex. 7 Ex. 5 Ex. 6 Ex. 7
    After 2 days no no no no no no
    After one month no no no 0.3% no no
    After 3 months 0.3% no no 0.7% no no
    After 6 months 0.5% no no 1.1% no no
  • TABLE 5-2
    Strength
    40° C. 75% RH 25° C. 60% RH
    Ex. 5 Ex. 6 Ex. 7 Ex. 5 Ex. 6 Ex. 7
    Before starting preservation 163 g 158 g 160 g 163 g 158 g 167 g
    After one month 189 g 155 g 161 g 169 g 158 g 165 g
    After 3 months 182 g 157 g 164 g 181 g 160 g 160 g
    After 6 months 180 g 164 g 166 g 178 g 159 g 163 g
  • TABLE 6-1
    Amount of syneresis Comp. Comp.
    (weight %) Ex. 8 Ex. 9 Ex. 10 ex. 7 ex. 8
    40° C. 75% RH
    After 2 days
    After one month 0.2% 0.2% 4.2% 9.0% 10.0% 
    After 3 months 0.5% 0.4% 5.2%
    After 6 months 0.8% 0.5% 5.0%
    25° C. 60% RH
    After 2 days 0.2% 0.2% 3.3% 0.9% 4.0%
    After one month 1.1% 1.2% 4.4% 8.4% 9.7%
    After 3 months 1.0% 1.3% 5.1%
    After 6 months 1.2% 1.4% 5.2%
  • TABLE 6-2
    Comp. Comp.
    Strength Ex. 8 Ex. 9 Ex. 10 ex. 7 ex. 8
    40° C. 75% RH
    Before starting preservation 276 g 109 g 103 g 105 g  68 g
    After one month 292 g 122 g 100 g  69 g 153 g
    After 3 months 286 g 118 g 111 g
    After 6 months 296 g 114 g
    25° C. 60% RH
    Before starting preservation 276 g 109 g 103 g 105 g  68 g
    After one month 287 g 111 g 114 g  64 g 139 g
    After 3 months 284 g 110 g 116 g
    After 6 months 282 g 118 g 118 g
  • TABLE 7
    Evaluation (Unit: person)
    Olganoleptic test ++ + ± −−
    Ex. 8 0 0 2 8 0
    Ex. 9 0 3 7 0 0
    Ex. 10 3 7 0 0 0
    Comp. ex. 7 1 9 0 0 0
    Comp. ex. 8 8 2 0 0 0
    Comp. ex. 9 10 0 0 0 0
    Control 10 0 0 0 0
    ++: too bitter to take one
    +: bitter
    ±: slightly bitter
    −: scarcely bitter
    −−: no bitter
  • INDUSTRIAL APPLICABILITY
  • In the present invention, by using at least one substance selected from the group consisting of carrageenan, carob bean gum and xanthan gum as a base (not containing phosphate buffer) of the jelly preparation containing a Chinese herbal medicine, a Chinese herbal medical composition in the form of jelly, which hardy muses syneresis, is superior in the preservative stability, is broadly applicable to a Chinese herbal medicine, and is orally taken without taking care of bitter, etc., of a Chinese herbal medicine is obtainable. Furthermore, even when the Chinese herbal medical composition in the form of jelly of the present invention can stand for the test for medicines, for example the long term-preservation test at 25° C. under 60% RH for 3 years, and the accelerated preservation test at 40° C. under 75% RH for 6 months and is guaranteed in the preservative stability.

Claims (19)

What is claimed is:
1. A Chinese herbal medical composition in the form of jelly, consisting of a Chinese herbal medicine in a base,
wherein the Chinese herbal medicine is selected from the group consisting of Hachimi-jio-gan, Keishi-bukuryo-gan, and Seijo-bofu-to, and is present in an amount less than 60 w/w % per total amount of the composition,
wherein the base consists of 0.01 to 10.0 w/w % carrageenan, 0.01 to 10.0 w/w % carob bean gum, 0.01 to 10.0 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative,
wherein the carrageenan is iota carrageenan or kappa carrageenan, or a mixture thereof and
wherein the base does not include a phosphate buffer or agar.
2. The Chinese herbal medical composition according to claim 1,
wherein the Chinese herbal medicine is present in an amount less than 50 w/w % per total amount of the composition, and
wherein the base consists of 0.05 to 5.0 w/w % carrageenan, 0.05 to 5.0 w/w % carob bean gum, and 0.05 to 5.0 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
3. The Chinese herbal medical composition according to claim 1,
wherein the Chinese herbal medicine is present in an amount less than 30 w/w % per total amount of the composition, and
wherein the base consists of 0.08 to 2.0 w/w % carrageenan, 0.1 to 2.0 w/w % carob bean gum, and 0.08 to 2.0 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
4. The Chinese herbal medical composition according to claim 1, wherein the amount of the Chinese herbal medicine is 14 w/w % or more per total amount of the composition.
5. The Chinese herbal medical composition according to claim 1,
wherein the Chinese herbal medicine is Hachimi-jio-gan, and is present in an amount of 14 w/w % per total amount of the composition.
6. The Chinese herbal medical composition according to claim 5,
wherein the base consists of 1 w/w % carrageenan, 0.2 w/w % carob bean gum, and 0.4 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
7. The Chinese herbal medical composition according to claim 6,
wherein the at least one pharmaceutically acceptable additive present in the base are 6 w/w % hydrogenated maltose starch syrup, 6 w/w % D-sorbitol, 6 w/w % glycerin, 1 w/w % propylene glycol, 0.02 w/w % propyl parahydroxybenzoate, and 65.38 w/w % water, per total amount of the composition.
8. The Chinese herbal medical composition according to claim 1,
wherein the Chinese herbal medicine is Keishi-bukuryo-gan, and is present in an amount of 14 w/w % per total amount of the composition.
9. The Chinese herbal medical composition according to claim 8,
wherein the base consists of 1 w/w % carrageenan, 0.25 w/w % carob bean gum, and 0.45 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
10. The Chinese herbal medical composition according to claim 9,
wherein the at least one pharmaceutically acceptable additive present in the base are 6 w/w % hydrogenated maltose starch syrup, 6 w/w % D-sorbitol, 6 w/w % glycerin, 1 w/w % propylene glycol, 0.02 w/w % propyl parahydroxybenzoate, and 65.28 w/w % water, per total amount of the composition.
11. The Chinese herbal medical composition according to claim 8,
wherein the base consists of 1.1 w/w % carrageenan, 0.25 w/w % carob bean gum, and 0.45 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
12. The Chinese herbal medical composition according to claim 11,
wherein the at least one pharmaceutically acceptable additive present in the base are 6 w/w % hydrogenated maltose starch syrup, 6 w/w % D-sorbitol, 6 w/w % glycerin, 1 w/w % propylene glycol, 0.02 w/w % propyl parahydroxybenzoate, and 65.18 w/w % water, per total amount of the composition.
13. The Chinese herbal medical composition according to claim 1 wherein the Chinese herbal medicine is Seijo-bofu-to, and is present in an amount of 14 w/w % per total amount of the composition.
14. The Chinese herbal medical composition according to claim 13,
wherein the base consists of 1 w/w % carrageenan, 0.2 w/w % carob bean gum, and 0.4 w/w % xanthan gum, per total amount of the composition, and at least one pharmaceutically acceptable additive selected from the group consisting of a stabilizing agent, a corrective agent, an emulsifying agent, a dispersion agent, a sweetening agent, a flavoring agent, a coloring agent, and a preservative.
15. The Chinese herbal medical composition according to claim 14,
wherein the at least one pharmaceutically acceptable additive present in the base are 6 w/w % hydrogenated maltose starch syrup, 6 w/w % D-sorbitol, 6 w/w % glycerin, 1 w/w % propylene glycol, 0.02 w/w % propyl parahydroxybenzoate, and 65.38 w/w % water, per total amount of the composition.
16. The Chinese herbal medical composition according to claim 14,
wherein the at least one pharmaceutically acceptable additive present in the base are 0.02 w/w % propyl parahydroxybenzoate and 84.38 w/w % water, per total amount of the composition.
17. The Chinese herbal medical composition according to claim 1,
wherein the at least one pharmaceutically acceptable additive present in the base are at least one sweetening agent, at least one dispersion agent, and at least one preservative.
18. The Chinese herbal medical composition according to claim 17, wherein:
the at least one sweetening agent is selected from the group consisting of glucose, fructose, saccharin sodium, sucrose, D-sorbitol, D-mannitol, and hydrogenated maltose starch syrup,
the at least one dispersion agent is selected from the group consisting of glycerin, propylene glycol, and water, and
the preservative is propyl parahydroxybenzoate.
19. A process for preparing the Chinese herbal medical composition according to claim 1, comprising:
mixing the Hachimi-jio-gan, Keishi-bukuryo-gan, or Seijo-bofu-to with the carrageenan, the carob bean gum, the xanthan gum, and the at least one pharmaceutically acceptable additive, and
then adding warm water to the mixture or adding water to the mixture and further warming it,
wherein the resulting composition is stable.
US15/150,745 2002-07-29 2016-05-10 Chinese herb medicine composition in the form of jelly Abandoned US20160250336A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/150,745 US20160250336A1 (en) 2002-07-29 2016-05-10 Chinese herb medicine composition in the form of jelly

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002-220191 2002-07-29
JP2002220191A JP5153045B2 (en) 2002-07-29 2002-07-29 Kampo jelly pharmaceutical composition
PCT/JP2003/009529 WO2004010969A1 (en) 2002-07-29 2003-07-28 Chinese herb medicine composition in the form of jelly
US52260305A 2005-01-26 2005-01-26
US15/150,745 US20160250336A1 (en) 2002-07-29 2016-05-10 Chinese herb medicine composition in the form of jelly

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/522,603 Division US9364428B2 (en) 2002-07-29 2003-07-28 Herb medicine composition in the form of jelly
PCT/JP2003/009529 Division WO2004010969A1 (en) 2002-07-29 2003-07-28 Chinese herb medicine composition in the form of jelly

Publications (1)

Publication Number Publication Date
US20160250336A1 true US20160250336A1 (en) 2016-09-01

Family

ID=31184758

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/522,603 Expired - Fee Related US9364428B2 (en) 2002-07-29 2003-07-28 Herb medicine composition in the form of jelly
US15/150,745 Abandoned US20160250336A1 (en) 2002-07-29 2016-05-10 Chinese herb medicine composition in the form of jelly

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/522,603 Expired - Fee Related US9364428B2 (en) 2002-07-29 2003-07-28 Herb medicine composition in the form of jelly

Country Status (8)

Country Link
US (2) US9364428B2 (en)
EP (1) EP1541130B1 (en)
JP (1) JP5153045B2 (en)
KR (1) KR101144460B1 (en)
CN (1) CN100482279C (en)
CA (1) CA2492490C (en)
HK (1) HK1076751A1 (en)
WO (1) WO2004010969A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9452150B2 (en) 2004-08-18 2016-09-27 Mochida Pharmaceutical Co., Ltd. Jelly composition
US20070128285A1 (en) * 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration
JP4955287B2 (en) * 2006-03-10 2012-06-20 大鵬薬品工業株式会社 Paeoniflorin-containing jelly preparation
JP2008044870A (en) * 2006-08-11 2008-02-28 Elmed Eisai Kk Pharmaceutical composition and its production method
EP2320753B1 (en) * 2008-09-05 2011-12-21 Unilever N.V. Beverages comprising potassium
CN103721264B (en) * 2014-01-12 2016-09-21 江苏祈瑞医药有限公司 A kind of for helping the gel swallowing oral solid pharmaceutical formulation
JP6339906B2 (en) * 2014-09-12 2018-06-06 松浦薬業株式会社 Kampo jelly pharmaceutical composition
JP6339907B2 (en) * 2014-09-12 2018-06-06 松浦薬業株式会社 Kampo jelly pharmaceutical composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932235A (en) * 1996-01-12 1999-08-03 Ohta Pharmaceutical Co., Ltd. Jellied medicinal composition for oral administration

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5470420A (en) * 1977-11-10 1979-06-06 Sanei Kagaku Kogyo Kk Binder for medical tablet
GB8628068D0 (en) * 1986-11-24 1986-12-31 Unilever Plc Aqueous gel comprising carrageenan
JPH0643326B2 (en) * 1987-03-27 1994-06-08 株式会社ツムラ Immunostimulant
JPS63279762A (en) * 1987-05-11 1988-11-16 Nitto Electric Ind Co Ltd Ginseng-containing food
JPH03247699A (en) 1990-02-26 1991-11-05 Marufuku Yushi Kogyo Kk Oil-gelling agent
JP2508555B2 (en) * 1991-05-24 1996-06-19 株式会社紀文食品 Bitterness reduction method
JPH07118161A (en) * 1993-05-24 1995-05-09 Tsumura & Co Antiviral agent
JPH0912463A (en) * 1995-06-23 1997-01-14 Fujisawa Pharmaceut Co Ltd Orally chewable preparation
CA2188331A1 (en) * 1995-10-19 1997-04-20 Timothy J. Young Bakery shortening substitute, bakery products containing the same, and preparation method
JPH09286735A (en) * 1996-04-23 1997-11-04 Taisho Pharmaceut Co Ltd Liquid drug for internal use
JP3511455B2 (en) * 1996-12-12 2004-03-29 花王株式会社 Cosmetics
JP3774975B2 (en) * 1997-02-25 2006-05-17 大正製薬株式会社 Gel-like sustained release composition
ES2197494T3 (en) * 1997-07-11 2004-01-01 Unilever N.V. CONTINUOUS WATERPROOF EMULSIONS THAT CAN FLOW.
US6277395B1 (en) * 1998-07-31 2001-08-21 Ryukakusan Co. Ltd. Swallowing-assistive drink
JP3257983B2 (en) * 1997-07-31 2002-02-18 株式会社龍角散 Drug swallowing aid drink
JPH11217329A (en) * 1998-01-30 1999-08-10 Sanpo Seiyaku Kk Solidified analeptic
WO2000024273A1 (en) * 1998-10-28 2000-05-04 San-Ei Gen F.F.I., Inc. Compositions containing sucralose and application thereof
JP2000281562A (en) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd Gel-like composition
JP5241978B2 (en) * 1999-10-13 2013-07-17 帝國製薬株式会社 Kampo jelly pharmaceutical composition
JP2001226293A (en) * 2000-02-17 2001-08-21 Kotaro Kanpo Seiyaku Kk Taking assisting agent
JP2002084977A (en) * 2000-07-14 2002-03-26 Masako Takatsu Sweet jelly, method for making the same, and confectionery made by using the same
JP2002249437A (en) 2001-02-22 2002-09-06 Api Co Ltd Health builder and composition thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932235A (en) * 1996-01-12 1999-08-03 Ohta Pharmaceutical Co., Ltd. Jellied medicinal composition for oral administration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Glycerol 2018 (https://pubchem.ncbi.nlm.nih.gov/compound/glycerol) *
Locust bean gum 2018 (http://www.absoluteastronomy.com/topics/Locust_bean_gum) *

Also Published As

Publication number Publication date
US9364428B2 (en) 2016-06-14
EP1541130B1 (en) 2014-05-07
AU2003252709A1 (en) 2004-02-16
HK1076751A1 (en) 2006-01-27
JP2004059503A (en) 2004-02-26
EP1541130A1 (en) 2005-06-15
US20050175628A1 (en) 2005-08-11
KR101144460B1 (en) 2012-05-11
WO2004010969A1 (en) 2004-02-05
KR20050026527A (en) 2005-03-15
EP1541130A4 (en) 2009-01-07
CN1671359A (en) 2005-09-21
CA2492490A1 (en) 2004-02-05
CA2492490C (en) 2014-07-08
JP5153045B2 (en) 2013-02-27
CN100482279C (en) 2009-04-29

Similar Documents

Publication Publication Date Title
US20160250336A1 (en) Chinese herb medicine composition in the form of jelly
KR100764531B1 (en) Jellied medicinal composition for oral administration
KR0161969B1 (en) Aqueous pharmaceutical suspension for substantially water-insoluble pharmaceutical actives
KR100451269B1 (en) Pharmaceutical antacid composition for oral administration
JP3257983B2 (en) Drug swallowing aid drink
US9737609B2 (en) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions
EA018401B1 (en) Liquid pharmaceutical formulation containing paracetamol
JP2004099558A (en) Jelly formulation for pharmaceutical use
JP5241978B2 (en) Kampo jelly pharmaceutical composition
JP4309481B2 (en) Jelly oral pharmaceutical composition
JP2017137246A (en) Chinese medicine jelly pharmaceutical composition
JPH11180864A (en) Jelly preparation containing alkali citrate
JPH085784B2 (en) Syrup
Anitha et al. Pharmaceutical Oral Jellies-An Overview
JP2003342186A (en) Oral liquid formulation composition for rhinitis
JP2003183162A (en) Oral cimetidine preparation
CN110840825A (en) Gel composition, preparation method and application thereof
JPH0516405B2 (en)
JPH0819000B2 (en) Syrup
JPH02221232A (en) Readily drinkable medicine composition
JP2003286184A (en) Antiallergic agent containing aqueous extracts of eucalyptus citriodora and cynara scolymus, and food product containing them
KR20030047503A (en) Sobrerol ·acetaminophen combined dry syrup and solution

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE